Baicalein inhibits progression of gallbladder cancer cells by downregulating ZFX

黄芩素通过下调 ZFX 抑制胆囊癌细胞进展

阅读:16
作者:Tian-Yu Liu, Wei Gong, Zhu-Jun Tan, Wei Lu, Xiang-Song Wu, Hao Weng, Qian Ding, Yi-Jun Shu, Run-Fa Bao, Yang Cao, Xu-An Wang, Fei Zhang, Huai-Feng Li, Shan-Shan Xiang, Lin Jiang, Yun-Ping Hu, Jia-Sheng Mu, Mao-Lan Li, Wen-Guang Wu, Bai-Yong Shen, Li-Xin Jiang, Ying-Bin Liu

Abstract

Baicalein, a widely used Chinese herbal medicine, has multiple pharmacological activities. However, the precise mechanisms of the anti-proliferation and anti-metastatic effects of baicalein on gallbladder cancer (GBC) remain poorly understood. Therefore, the aim of this study was to assess the anti-proliferation and anti-metastatic effects of baicalein and the related mechanism(s) on GBC. In the present study, we found that treatment with baicalein induced a significant inhibitory effect on proliferation and promoted apoptosis in GBC-SD and SGC996 cells, two widely used gallbladder cancer cell lines. Additionally, treatment with baicalein inhibited the metastasis of GBC cells. Moreover, we demonstrated for the first time that baicalein inhibited GBC cell growth and metastasis via down-regulation of the expression level of Zinc finger protein X-linked (ZFX). In conclusion, our studies suggest that baicalein may be a potential phytochemical flavonoid for therapeutics of GBC and ZFX may serve as a molecular marker or predictive target for GBC.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。